CSO: Paul Rennert

Advent Contact: Raj Parekh

Immuno-oncology platform focused on cell therapy

Aleta is an immuno-oncology company focused on transforming cellular therapeutics to allow a broader spectrum of cancer indications to be targeted, including some currently intractable solid tumours.

Advent founded Aleta in 2015.

Back